Published • loading... • Updated
Parnell Launches Nixiflor® - First Fda-Approved Generic Florfenicol + Flunixin Combination for Brd
Summary by The Bakersfield Californian
7 Articles
7 Articles
Reposted by
Southernminn.com
Parnell Technologies launches FDA-approved generic for bovine respiratory disease
Parnell Technologies Pty. Ltd. announced the U.S. launch of nixiFLOR (florfenicol and flunixin meglumine) injectable solution, recently approved by the U.S. Food and Drug Administration for the treatment of bovine respiratory disease (BRD) and control of BRD-associated fever in beef…
+4 Reposted by 4 other sources
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Apr 1, 2026-
Coverage Details
Total News Sources7
Leaning Left2Leaning Right0Center2Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium





